Atezolizumab,nivolumab,Pembrolizumab,Ipilimumab
merck,roche,bms
['nivo', 'atezo', 'pembro']
an excellent balanced, comprehensive discussion from #esmo22 on the trials reported thus far for adjuvant #kidneycancer. pembrolizumab activity not replicated with atezo &amp; nivo but these unhappy neg trials have each their own reason for not achieving initial goal. 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe